52 North Health is a startup based in the United Kingdom, most recent round Series-c-plus, 1 tracked investor.
52 North Health is a startup founded in 2020 based in the United Kingdom. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
52 North Health develops affordable, patient-centered medical technology solutions for cancer patients, primarily focusing on the NeutroCheck device, which uses a finger-prick blood test and AI to monitor risk of neutropenic sepsis in patients undergoing chemotherapy, enabling at-home monitoring and improving health outcomes and equity.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.